Therapeutic agents for machine perfusion of donor organs
Open Access
- 22 March 2024
- journal article
- research article
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 16 (1) , 116-134
Abstract
Background. The urgency of the unmet need for transplant care dictates the necessity to use organs from suboptimal donors. Machine perfusion, which is actively developing at the present time, is designated to solve this problem. The literature presents novel technologies of ex vivo and in vivo machine perfusion of donor organs, which make it possible to improve their functions and perform a successful transplant. The most promising areas of research both in animals and in humans may be identified by reviewing the literature sources on this subject.The aim was to analyze the world experience of using therapeutic agents in machine perfusion of donor organsMaterial and methods: sources from 2015 to 2023 found in PubMed, Google Scholar, eLibrary databasesConclusion. The rapid progress in lung, liver and kidney transplantation has made it possible to use grafts from asystolic donors for patients in urgent need of donor organs. In turn, these advances have also prompted the study of potential therapeutic agents that can be used during perfusion.Keywords
This publication has 60 references indexed in Scilit:
- Gene Silencing With siRNA (RNA Interference): A New Therapeutic Option During Ex Vivo Machine Liver Perfusion PreservationLiver Transplantation, 2018
- Bronchodilator Inhalation During Ex Vivo Lung Perfusion Improves Posttransplant Graft Function After Warm IschemiaThe Annals of Thoracic Surgery, 2017
- Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant TherapyThe Annals of Thoracic Surgery, 2016
- Anti‐inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantationLiver Transplantation, 2016
- β2-Adrenoreceptor Agonist Inhalation During Ex Vivo Lung Perfusion Attenuates Lung InjuryThe Annals of Thoracic Surgery, 2015
- β-Adrenergic agonist infusion during extracorporeal lung perfusion: Effects on glucose concentration in the perfusion fluid and on lung functionThe Journal of Heart and Lung Transplantation, 2012
- Adenosine A2A Agonist Improves Lung Function During Ex Vivo Lung PerfusionThe Annals of Thoracic Surgery, 2011
- Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1β in isolated hemoperfused kidneysEuropean Journal of Pharmacology, 2011
- Fibrinolytic Treatment Improves the Quality of Lungs Retrieved From Non-Heart-Beating DonorsThe Journal of Heart and Lung Transplantation, 2007
- Protective Effect of a Nebulized β2-Adrenoreceptor Agonist in Warm Ischemic–Reperfused Rat LungsThe Annals of Thoracic Surgery, 2006